Kohlberg Kravis Roberts & Co. L.P. Bausch Health Companies Inc. Transaction History
Kohlberg Kravis Roberts & Co. L.P.
- $2.17 Billion
- Q1 2025
A detailed history of Kohlberg Kravis Roberts & Co. L.P. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Kohlberg Kravis Roberts & Co. L.P. holds 5,235,000 shares of BHC stock, worth $25.4 Million. This represents 1.56% of its overall portfolio holdings.
Number of Shares
5,235,000
Previous 5,235,000
-0.0%
Holding current value
$25.4 Million
Previous $42.2 Million
19.73%
% of portfolio
1.56%
Previous 2.74%
Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
243MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$169 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$147 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$128 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$114 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$63.2 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.76B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...